Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Netrin 4 ELISA Kit (AC2754)
Cat.#: ASET-1343
Specifications
Description Human Netrin 4 ELISA Kit allows for the in vitro quantitative determination of human Netrin 4 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1361 Sheep Inhibin beta B ELISA Kit (AC2772) Quantitative inquiry ASET-2178 Mouse Aldh1a7 ELISA Kit (AC3589) Quantitative inquiry ASET-1366 Rat Nestin ELISA Kit (AC2777) Quantitative inquiry ASET-1524 Porcine ACTH ELISA Kit (AC2935) Quantitative inquiry ASET-1395 Rat Glucose 6 Phosphate Isomerase ELISA Kit (AC2806) Quantitative inquiry ASET-1907 Human NOSTRIN ELISA Kit (AC3318) Quantitative inquiry ASET-2516 Mouse alpha B Crystallin ELISA Kit (AC3927) Quantitative inquiry ASET-1949 Human KCNJ14 ELISA Kit (AC3360) Quantitative inquiry ASET-1687 Mouse Neogenin ELISA Kit (AC3098) Quantitative inquiry ASET-1424 Human Semaphorin 3F ELISA Kit (AC2835) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket